Expression Patterns of Macrophage Migration Inhibitory Factor and Its Gene Variants (MIF-173 G˃C) in Verruca Vulgaris

References

• Gibbs S. Local treatments for cutaneous warts: systematic review. BMJ. 2002;325:461. doi:10.1136/bmj.325.7362.461
   PubMed Web of Science ®Google Scholar
• Ralph J, O’Grady C, Boggs J, Barry R. Remission of verruca vulgaris following incisional punch biopsy. Clin Exp Dermatol. 2021;46:1163–1165. doi:10.1111/ced.14613
   PubMed Web of Science ®Google Scholar
• Deligeoroglou E, Giannouli A, Athanasopoulos N, et al. HPV infection: immunological aspects and their utility in future therapy. Infect Dis Obstet Gynecol. 2013;2013:540850. doi:10.1155/2013/540850
   PubMedGoogle Scholar
• Ma JE, Brewer JD. Merkel cell carcinoma in immunosuppressed patients. Cancers. 2014;6(3):1328–1350. doi:10.3390/cancers6031328
   PubMed Web of Science ®Google Scholar
• Drago F, Ciccarese G, Broccolo F, et al. The role of cytokines, chemokines, and growth factors in the pathogenesis of pityriasis rosea. Mediators Inflamm. 2015;2015:438963. doi:10.1155/2015/438963
   PubMed Web of Science ®Google Scholar
• Cush SS, Reynoso GV, Kamenyeva O, et al. Locally produced IL-10 limits cutaneous vaccinia virus spread. PLoS Pathog. 2016;12(3):e1005493. doi:10.1371/journal.ppat.1005493
   PubMed Web of Science ®Google Scholar
• Garcia M, Alout H, Diop F, et al. Innate immune response of primary human keratinocytes to west nile virus infection and its modulation by mosquito saliva. Front Cell Infect Microbiol. 2018;8:387. doi:10.3389/fcimb.2018.00387
   PubMed Web of Science ®Google Scholar
• Sahu U, Biswas D, Prajapati VK, Singh AK, Samant M, Khare P. Interleukin-17-A multifaceted cytokine in viral infections. J Cell Physiol. 2021;236(12):8000–8019. doi:10.1002/jcp.30471
   PubMed Web of Science ®Google Scholar
• Lei V, Petty AJ, Atwater AR, Wolfe SA, MacLeod AS. Skin viral infections: host antiviral innate immunity and viral immune evasion. Front. Immunol. 2020;11:593901. doi:10.3389/fimmu.2020.593901
   PubMed Web of Science ®Google Scholar
• Donn RP, Ray DW. Macrophage migration inhibitory factor: molecular, cellular and genetic aspects of a key neuroendocrine molecule. J Endocrinol. 2004;182:1–9. doi:10.1677/joe.0.1820001
   PubMed Web of Science ®Google Scholar
• Leech M, Lacey D, Xue JR, et al. Regulation of p53 by macrophage migration inhibitory factor in inflammatory arthritis. Arthritis Rheum. 2003;48:1881–1889. doi:10.1002/art.11165
   PubMed Web of Science ®Google Scholar
• Castañeda-Moreno VA, De la Cruz-Mosso U, Torres-Carrillo N, et al. MIF functional polymorphisms (−794 CATT 5–8 and −173 G>C) are associated with MIF serum levels, severity and progression in male multiple sclerosis from western Mexican population. J Neuroimmunol. 2018;320:117–124. doi:10.1016/j.jneuroim.2018.04.006
   PubMed Web of Science ®Google Scholar
• De la Cruz-Mosso U, Bucala R, Palafox-Sánchez CA, et al. Macrophage migration inhibitory factor: association of −794 CATT5–8 and −173 G>C polymorphisms with TNF-α in systemic lupus erythematosus. Hum Immunol. 2014;75(5):433–439. doi:10.1016/j.humimm.2014.02.014
   PubMed Web of Science ®Google Scholar
• El-Hamd MA, Assaf HA, Nada EA. Possible role of interleukin-17 and macrophage migration inhibitory factor in cutaneous warts. J Cosmet Dermatol. 2018;17:1250–1253. doi:10.1111/jocd.12472
   PubMed Web of Science ®Google Scholar
• Sorour NE, Hamed AM, Tabl HAM, Ahmed AAA. Assessment of macrophage migration inhibitory factor in patients with verruca vulgaris. Clin Cosmet Investig Dermatol. 2019;12:591–595. doi:10.2147/CCID.S209269
   PubMed Web of Science ®Google Scholar
• Assaf HA, AbdelMaged WM, Elsadek BE, Hassan MH, Adly MA, Ali SA. Survivin as a novel biomarker in the pathogenesis of acne vulgaris and its correlation to insulin-like growth factor-I. Dis Markers. 2016;2016:7040312. doi:10.1155/2016/7040312
   PubMed Web of Science ®Google Scholar
• Elsadek B, Mansour A, Saleem T, Warnecke A, Kratz F. The antitumor activity of a lactosaminated albumin conjugate of doxorubicin in a chemically induced hepatocellular carcinoma rat model compared to sorafenib. Dig Liver Dis. 2017;49:213–222. doi:10.1016/j.dld.2016.10.003
   PubMedGoogle Scholar
• Hassan MH, Abuhamdah S, Abdel-Bary M, et al. Circulating and local nuclear expression of survivin and fibulin-3 genes in discriminating benign from malignant respiratory diseases: correlation analysis. Biosci Rep. 2021;41(1):BSR20203097. doi:10.1042/BSR20203097
   PubMed Web of Science ®Google Scholar
• Col-Araz N, Oguzkan-Balci S, Baspinar O, Sever T, Balat A, Pehlivan S. Mannose binding lectin and macrophage migration inhibitory factor gene polymorphisms in Turkish children with cardiomyopathy: no association with MBL2 Codon 54 A/B genotype, but an association between MIF −173 CC genotype. Int J Med Sci. 2012;9(6):506–512. doi:10.7150/ijms.4787
   PubMed Web of Science ®Google Scholar
• El-Mahdy RI, Saleem TH, Essam OM, Algowhary M. Functional variants in the promoter region of macrophage migration inhibitory factor rs755622 gene (MIF G173C) among patients with heart failure: association with echocardiographic indices and disease severity. Heart Lung. 2021;50:92–100.
   PubMed Web of Science ®Google Scholar
• Hardy GH. Mendelian proportions in a mixed population. Science. 1908;28:49–50. doi:10.1126/science.28.706.49
   PubMedGoogle Scholar
• Stark AE. A clarification of the Hardy-Weinberg law. Genetics. 2006;174:1695–1697. doi:10.1534/genetics.106.057042
   PubMed Web of Science ®Google Scholar
• Palefsky J, Holly E, Ralston M, Jay N. Prevalence and risk factors for human papillomavirus infection of the anal canal in human immunodeficiency virus (HIV)-positive and HIV-negative homosexual men. J Infect Dis. 1998;177:361–367. doi:10.1086/514194
   PubMed Web of Science ®Google Scholar
• Zhao Y, Shimizu T, Nishihira J, et al. Tissue regeneration using macrophage migration inhibitory factor (MIF)-impregnated gelatin microbeads in cutaneous wounds. Am J Pathol. 2005;167:1519–1529. doi:10.1016/S0002-9440(10)61238-2
   PubMed Web of Science ®Google Scholar
• Shimizu T. The role of macrophage migration inhibitory factor (MIF) in ultraviolet radiation-induced carcinogenesis. Cancers. 2010;2:1555–1564. doi:10.3390/cancers2031555
   PubMedGoogle Scholar
• Feily A, Yaghoobi R, Pazyar N. Macrophage migration inhibitory factor as an incriminating agent in dermatological disorders. Indian J Dermatol. 2013;58(2):157. doi:10.4103/0019-5154.108068
   PubMedGoogle Scholar
• Garcia-Orozco A, Martinez-Magaña IA, Riera-Leal A, et al. Macrophage inhibitory factor (MIF) gene polymorphisms are associated with disease susceptibility and with circulating MIF levels in active non-segmental vitiligo in patients from western Mexico. Mol Genet Genomic Med. 2020;8(10):e1416. doi:10.1002/mgg3.1416
   PubMed Web of Science ®Google Scholar
• Kuai SG, Ou QF, You DH, et al. Functional polymorphisms in the gene encoding macrophage migration inhibitory factor (MIF) are associated with active pulmonary tuberculosis. Infect Dis. 2016;48(3):222–228. doi:10.3109/23744235.2015.1107188
   PubMed Web of Science ®Google Scholar
• Calandra T, Bernhagen J, Metz CN, et al. MIF as a glucocorticoid‐induced modulator of cytokine production. Nature. 1995;377(6544):68–71. doi:10.1038/377068a0
   PubMed Web of Science ®Google Scholar
• Calandra T, Roger T. Macrophage migration inhibitory factor: a regulator of innate immunity. Nat Rev Immunol. 2003;3(10):791–800. doi:10.1038/nri1200
   PubMed Web of Science ®Google Scholar
• Brocks T, Fedorchenko O, Schliermann N, et al. Macrophage migration inhibitory factor protects from nonmelanoma epidermal tumors by regulating the number of antigen-presenting cells in skin. FASEB J. 2016;31:526–543. doi:10.1096/fj.201600860R
   PubMed Web of Science ®Google Scholar
• Shimizu T, Abe R, Nishihira J, et al. Impaired contact hypersensitivity in macrophage migration inhibitory factor-deficient mice. Eur J Immunol. 2003;33(6):1478–1487. doi:10.1002/eji.200323751
   PubMed Web of Science ®Google Scholar
• Coleman N, Birley HD, Renton AM, et al. Immunological events in regressing genital warts. Am J Clin Pathol. 1994;102:768–774. doi:10.1093/ajcp/102.6.768
   PubMed Web of Science ®Google Scholar
• Nassar A, Nofal A, Bakr NM, Essam R, Alakad R. Correlation of serum interleukin 17 and macrophage migration inhibitory factor levels with clinical response to intralesional candida antigen and their potential use as predictors of clinical outcome in patients with multiple common warts. J Cosmet Dermatol. 2021;1–9. doi:10.1111/jocd.14688
   Web of Science ®Google Scholar
• Abe R, Peng T, Sailors J, Bucala R, Metz CN. Regulation of the CTL response by macrophage migration inhibitory factor. J Immunol. 2001;166:747–753. doi:10.4049/jimmunol.166.2.747
   PubMed Web of Science ®Google Scholar
• Mogensen SC. Macrophage migration inhibition as a correlate of cell-mediated immunity to herpes simplex virus type 2 in mice. Immunobiology. 1982;162(1):28–38. doi:10.1016/S0171-2985(11)80014-8
   PubMed Web of Science ®Google Scholar
• Hou XQ, Gao YW, Yang ST, Wang CY, Ma ZY, Xia XZ. Role of macrophage migration factor inhibitor in influenza H5N1 virus pneumonia. ActaVirologica. 2009;53(4):225–231.
   Google Scholar
• Delaloye J, De Bruin IJA, Darling EA, et al. Increased macrophage migration factor inhibitor (MIF) plasma levels in acute HIV-1 infection. Cytokine. 2012;60(2):338–340. doi:10.1016/j.cyto.2012.07.027
   PubMed Web of Science ®Google Scholar
• Scott M, Nakagawa M, Moscicki AB. Cell-mediated immune response to human papillomavirus infection. Clin Diagn Lab Immunol. 2001;8:209–220. doi:10.1128/CDLI.8.2.209-220.2001
   PubMedGoogle Scholar
• Stanley MA, Pett MR, Coleman N. HPV: from infection to cancer. BiochemSoc Trans. 2007;35:1456–1460. doi:10.1042/BST0351456
   PubMed Web of Science ®Google Scholar
• Frazer IH. Interaction of human papillomaviruses with the host immune system: a well evolved relationship. Virology. 2009;384:410–414. doi:10.1016/j.virol.2008.10.004
   PubMed Web of Science ®Google Scholar
• Donn R, Alourfi Z, De Benedetti F, et al. Mutation screening of the macrophage migration inhibitory factor gene: positive association of a functional polymorphism of macrophage migration inhibitory factor with juvenile idiopathic arthritis. Arthritis Rheum. 2002;46:2402–2409. doi:10.1002/art.10492
   PubMed Web of Science ®Google Scholar
• Renner P, Roger T, Calandra T. Macrophage migration inhibitory factor: gene polymorphisms and susceptibility to inflammatory diseases. Clin Infect Dis. 2005;41(Suppl 7):S513–S519. doi:10.1086/432009
   PubMed Web of Science ®Google Scholar